Table I.
Case | Age/sex | Time to diagnosis (y) | Sites of acneiform lesions | DIF | Concurrent SLE | Antinuclear antibody | Treatments | Follow-up |
---|---|---|---|---|---|---|---|---|
Haroon and Fleming2 | 28/F | 6 | Upper arms, shoulders, back | Positive | No | Negative | — | — |
Motel et al3 | 29/F | 7 | Face, upper trunk | Negative | Yes | Positive (1:2560) homogenous | Tetracycline, erythromycin | No improvement |
Motel et al3 | 24/F | — | Face, neck | IgG in nucleoli of focal keratinocytes | Yes | Positive (1:5120) nucleolar | Erythromycin 250 mg QID | No improvement |
Chang et al4 | 32/M | 3 | Right nasolabial fold | IgG + C3 along BMZ | No | Negative | — | — |
Stavrakoglou et al5 | 38/M | 7 | Face, chest, back | Negative | No | Negative |
|
|
Hemmati et al6 | 33/F | 1.5 | Scalp | — | No | — |
|
|
Farias et al7 | 35/F | 2 | Face, ear | — | No | — |
|
|
Vieira et al8 | 32/F | 2 | Face | IgM along BMZ and upper dermal vessels | No | Negative | Prednisone 40 mg × 1 mo then tapered over 4 mo + chloroquine, 250 mg daily | Significant improvement at 3 mo, no new lesions at 4 ys |
Current case | 57/F | 1 | Face, ears, neck | — | No | Positive (1:80) speckled | Topical clindamycin, tretinoin, benzoyl peroxide, oral doxycycline | No improvement |
BID, Twice daily; BMZ, basement membrane zone; DIF, direct immunofluorescence; ILTAC, intralesional triamcinolone; SLE, systemic lupus erythematosus; QID, 4 times daily.